Home Markets FDA probes death of patient on Sarepta’s Elevidys, partner Roche says death unrelated to therapy FDA probes death of patient on Sarepta’s Elevidys, partner Roche says death unrelated to therapy Andrew M Jul 26, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/us-fda-investigates-third-death-after-treatment-with-sareptas-gene-therapy-elevidys-4153940 FDA gene therapy Market Updates www.investing.com/news/stock-market-news/us-fda-investigates-third-death-after-treatment-with-sareptas-gene-therapy-elevidys-4153940